Clinical Trial Update: Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059) [Phase 4]

View source ↗

Summary

A phase 4 trial evaluating Caelyx (pegylated liposomal doxorubicin) as monotherapy in elderly patients with locally advanced or metastatic breast cancer was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Breast Neoplasms | Phase 4 | Status: TERMINATED | Results posted: 2011-05-02